Ebola medical therapy: Difference between revisions
Sergekorjian (talk | contribs) No edit summary |
Sergekorjian (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{GRN}} | {{CMG}}; {{AE}} {{GRN}} | ||
==Overview== | ==Overview== | ||
No specific [[antiviral drug]] has demonstrated effectiveness against Ebola infection. Management is primarily supportive and symptomatic. The following basic interventions, when used early, can significantly improve the chances of survival: providing [[intravenous fluid]]s | No specific [[antiviral drug]] has demonstrated effectiveness against Ebola infection. Management is primarily supportive and symptomatic. The following basic interventions, when used early, can significantly improve the chances of survival: providing [[intravenous fluid]]s and balancing [[electrolyte]]s, maintaining oxygen status and [[blood pressure]], and treating other infections if they occur. Some organizations have suggested the addition of broad-spectrum antimicrobials, particularly in patients with evidence of septic shock. | ||
==Medical Therapy== | ==Medical Therapy== | ||
Revision as of 17:49, 1 October 2014
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola medical therapy On the Web |
|
American Roentgen Ray Society Images of Ebola medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Guillermo Rodriguez Nava, M.D. [2]
Overview
No specific antiviral drug has demonstrated effectiveness against Ebola infection. Management is primarily supportive and symptomatic. The following basic interventions, when used early, can significantly improve the chances of survival: providing intravenous fluids and balancing electrolytes, maintaining oxygen status and blood pressure, and treating other infections if they occur. Some organizations have suggested the addition of broad-spectrum antimicrobials, particularly in patients with evidence of septic shock.
Medical Therapy
There are no targeted antiviral therapies currently in use. Treatment for Ebola is primarily supportive.
Bleeding
Replete coagulation factors with fresh frozen plasma if available, and transfuse with packed red blood cells and platelets as needed. Invasive procedures should be avoided to prevent further bleeding.
Dehydration
Replete with intravenous fluids with careful consideration of electrolyte imbalances.
Shock
Treat with a combination of intravenous fluids, vasopressors, and blood products as needed.
Hypoxia
Treat with supplemental oxygen including intubation if deemed necessary.
Superimposed Infections
Treating any complicating infections with empiric antibiotics.
References